Truncal Blocks Versus Wound Infiltration for SICD

August 2, 2022 updated by: Ali Nima Shariat, Icahn School of Medicine at Mount Sinai

Comparing Truncal Blocks Versus Wound Infiltration for Subcutaneous Implantable Cardioverter Defibrillator Implantation

This is a single-center, randomized and prospective trial of all patients undergoing S-ICD implantation. Subjects will only be eligible for this study if they are ≥ 18 years of age and eligible to undergo S-ICD implant at Mount Sinai Morningside Hospital. They will be randomized to receive either surgical infiltration of local anesthetic or truncal blocks. Intraoperative and postoperative data will be collected including total opioid use, pain scores postprocedure, total postoperative narcotic need and length of stay.

Study Overview

Detailed Description

This is a single-center, randomized and prospective trial of all patients undergoing S-ICD implantation. Subjects will only be eligible for this study if they are ≥ 18 years of age and eligible to undergo S-ICD implant at Mount Sinai Morningside Hospital. They will be randomized to receive either surgical infiltration of local anesthetic or truncal blocks. Intraoperative and postoperative data will be collected including total opioid use, pain scores postprocedure, total postoperative narcotic need and length of stay. The procedures involved for the study are the placement of the described truncal blocks or wound infiltration. Data to be collected are patient demographics, history of present illness, past medical history, and pain management techniques required (i.e non-narcotics and narcotics use). In addition, age, race, gender and BMI will also be collected. Intraoperative analgesia requirements, postoperative analgesia requirements, duration of procedure and length of stay will also be collected.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10025
        • Mount Sinai Morningside Hospital Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients over 18 years of age
  • Patients undergoing S-ICD placement

Exclusion Criteria:

  • Allergy to amide local anesthetics

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Wound infiltration
Standard intervention - surgical infiltration with local anesthetics
Surgical wound infiltration by proceduralist
Experimental: Truncal blocks
Truncal block for anesthetics
Truncal blocks provided by anesthesiology team for device placement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative and postoperative opioid consumption
Time Frame: Up to Post-Op Day 10
Total intraoperative and postoperative opioid consumption of subjects
Up to Post-Op Day 10

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Non-opioid analgesic consumption
Time Frame: Up to Post-Op Day 10
Total intraoperative and postoperative non-opioid analgesic consumption of subjects
Up to Post-Op Day 10
Sedation (propofol) requirements intraoperatively
Time Frame: Day 1, Day of Surgery
Total propofol required by subjects intraoperatively
Day 1, Day of Surgery
Number of participants with ICU stay
Time Frame: Up to Post-Op Day 10
Need of intensive care unit (ICU) stay
Up to Post-Op Day 10
Duration of ICU stay
Time Frame: Up to Post-Op Day 10
Duration of intensive care unit (ICU) stay
Up to Post-Op Day 10
Visual Analog Pain score
Time Frame: Up to Post-Op Day 10
Visual Analog Pain Score (VAS) - total scale from 0-10, with higher score indicating more pain
Up to Post-Op Day 10
Total procedure time
Time Frame: Day 1 at Surgery
Total duration of procedure time measured in minutes
Day 1 at Surgery
Length of stay
Time Frame: Day 1 at Surgery
Length of time in the postanesthesia care unit measured in minutes
Day 1 at Surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ali Shariat, MD, Icahn School Of Medicine At Mount Sinai

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 23, 2019

Primary Completion (Actual)

February 18, 2022

Study Completion (Actual)

February 18, 2022

Study Registration Dates

First Submitted

July 8, 2021

First Submitted That Met QC Criteria

July 22, 2021

First Posted (Actual)

July 23, 2021

Study Record Updates

Last Update Posted (Actual)

August 4, 2022

Last Update Submitted That Met QC Criteria

August 2, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe